1
|
Wu F, Liang S, Zhuang NB, Su YQ, Liang YL, Peng L, Xu YP, Shao CP. A new RHD variant allele caused by an RHD c.1228-1G>C mutation in a Chinese family. Transfusion 2021; 61:E55-E56. [PMID: 34291823 DOI: 10.1111/trf.16510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Revised: 03/12/2021] [Accepted: 04/28/2021] [Indexed: 11/30/2022]
Affiliation(s)
- Fan Wu
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Shuang Liang
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Nai-Bao Zhuang
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Yu-Qing Su
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Yan-Lian Liang
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Long Peng
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Yun-Ping Xu
- Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Chao-Peng Shao
- Department of Blood Transfusion, The First Affiliated Hospital of Shenzhen University School of Medicine, The Second People's Hospital of Shenzhen, Shenzhen, China
| |
Collapse
|
2
|
Seheult JN, Stram MN, Pearce T, Bub CB, Emery SP, Kutner J, Watanabe-Okochi N, Sperry JL, Takanashi M, Triulzi DJ, Yazer MH. The risk to future pregnancies of transfusing Rh(D)-negative females of childbearing potential with Rh(D)-positive red blood cells during trauma resuscitation is dependent on their age at transfusion. Vox Sang 2021; 116:831-840. [PMID: 33491789 DOI: 10.1111/vox.13065] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/16/2020] [Accepted: 12/30/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND A risk assessment model for predicting the risk of haemolytic disease of the fetus and newborn (HDFN) in future pregnancies following the transfusion of Rh(D)-positive red blood cell (RBC)-containing products to females of childbearing potential (FCP) was developed, accounting for the age that the FCP is transfused in various countries. METHODS The HDFN risk prediction model included the following inputs: risk of FCP death in trauma, Rh(D) alloimmunization rate following Rh(D)-positive RBC transfusion, expected number of live births following resuscitation, probability of carrying an Rh(D)-positive fetus, the probability of HDFN in an Rh(D)-positive fetus carried by an alloimmunized mother. The model was implemented in Microsoft R Open, and one million FCPs of each age between 18 and 49 years old were simulated. Published data from eight countries, including the United States, were utilized to generate country-specific HDFN risk estimates. RESULTS The risk predictions showed similar characteristics for each country in that the overall risk of having a pregnancy affected by HDFN was higher if the FCP was younger when she received her Rh(D)-positive transfusion than if she was older. In the United States, the overall risk of HDFN if the FCP was transfused at age 18 was 3·4% (mild: 1·20%, moderate: 0·45%; severe: 1·15%; IUFD: 0·57%); the risk was approximately 0% if the FCP was 43 years or older at the time of transfusion. CONCLUSION This model can be used to predict HDFN outcomes when establishing transfusion policies as it relates to the administration of Rh(D)-positive products for massively bleeding FCPs.
Collapse
Affiliation(s)
- Jansen N Seheult
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.,Vitalant, Pittsburgh, PA, USA
| | | | - Thomas Pearce
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | | | - Stephen P Emery
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Jose Kutner
- Hospital Israelita Albert Einstein, Sao Paulo, Brazil
| | | | - Jason L Sperry
- Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Minoko Takanashi
- Japanese Red Cross Society Blood Service Headquarters, Tokyo, Japan
| | - Darrell J Triulzi
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.,Vitalant, Pittsburgh, PA, USA
| | - Mark H Yazer
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.,Vitalant, Pittsburgh, PA, USA
| |
Collapse
|
3
|
Ji YL, Luo H, Wen JZ, Haer-Wigman L, Veldhuisen B, Wei L, Wang Z, Ligthart P, Lodén-van Straaten M, Fu YS, van der Schoot CE, Luo GP. RHDgenotype and zygosity analysis in the Chinese Southern Han D+, D− and D variant donors using the multiplex ligation-dependent probe amplification assay. Vox Sang 2017; 112:660-670. [DOI: 10.1111/vox.12554] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2017] [Revised: 06/14/2017] [Accepted: 06/23/2017] [Indexed: 12/25/2022]
Affiliation(s)
- Y. L. Ji
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
- Sanquin Research and Landsteiner Laboratory; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
| | - H. Luo
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
| | - J. Z. Wen
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
| | - L. Haer-Wigman
- Sanquin Research and Landsteiner Laboratory; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
| | - B. Veldhuisen
- Sanquin Research and Landsteiner Laboratory; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
- The Department of Immunohematology Diagnostics; Sanquin Diagnostic Services; Amsterdam The Netherlands
| | - L. Wei
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
| | - Z. Wang
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
| | - P. Ligthart
- The Department of Immunohematology Diagnostics; Sanquin Diagnostic Services; Amsterdam The Netherlands
| | | | - Y. S. Fu
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
| | - C. E. van der Schoot
- Sanquin Research and Landsteiner Laboratory; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
| | - G. P. Luo
- Guangzhou Blood Center; Institute of Clinical Blood Transfusion; Guangzhou China
| |
Collapse
|
4
|
Fu SJ, Feng YL, Yu LX, Miao Y, Luo M, Wang YB, Li YC, Chen SH, Xiao LL. [Genotyping of RhD-negative blood samples diagnosed by serological tests from patients waiting for kidney transplantation]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2017; 37:837-841. [PMID: 28669963 PMCID: PMC6744145 DOI: 10.3969/j.issn.1673-4254.2017.06.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Indexed: 06/07/2023]
Abstract
OBJECTIVE To compare the accuracy of serological and molecular approaches to identification of RhD-negative patients waiting for kidney transplantation. METHODS A total of 103 RhD-negative blood samples by serological test were collected from patients waiting for kidney transplantation between January, 2006 and January, 2016. Quantitative PCR and sequencing were used to verify the results of RHD genotyping, and the false negative rates of the serological and molecular methods for RhD genotyping were compared. RESULTS Among the 103 blood samples, true RhD negativity (with all the 10 exons missing) was found in 56 samples (54.5%), and false RhD negativity (RhD positivity with loss, repetition, or missense mutation in the 10 exons) in 47 samples (45.6%). In the 47 false RhD-negative cases, weak D was detected in 1 case (2.1%), partial D in 13 cases (27.7%), and D-elution in 33 cases (70.2%). The detection rates of RhD negativity differed significantly between the serological and molecular methods (P<0.05). CONCLUSION Serological test is associated with a high false negative rate in detecting RhD blood group, and the use of the molecular approach has important clinical significance in accurate RhD genotyping for patients waiting for renal transplantation.
Collapse
Affiliation(s)
- Shao-Jie Fu
- Department of Organ Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. E-mail:
| | | | | | | | | | | | | | | | | |
Collapse
|
5
|
McGowan EC, Lopez GH, Knauth CM, Liew YW, Condon JA, Ramadi L, Parsons K, Turner EM, Flower RL, Hyland CA. Diverse and novelRHDvariants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang 2017; 112:279-287. [DOI: 10.1111/vox.12488] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2016] [Revised: 12/21/2016] [Accepted: 12/21/2016] [Indexed: 12/13/2022]
Affiliation(s)
- E. C. McGowan
- Clinical Services and Research; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
| | - G. H. Lopez
- Clinical Services and Research; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
| | - C. M. Knauth
- Clinical Services and Research; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
- School of Biomedical Sciences; Faculty of Health; Queensland University of Technology; Brisbane QLD Australia
| | - Y.-W. Liew
- Red Cell Reference Laboratory; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
| | - J. A. Condon
- Red Cell Reference Laboratory; Australian Red Cross Blood Service; West Melbourne Vic. Australia
| | - L. Ramadi
- Red Cell Reference Laboratory; Australian Red Cross Blood Service; West Melbourne Vic. Australia
| | - K. Parsons
- Red Cell Reference Laboratory; Australian Red Cross Blood Service; Alexandria NSW Australia
| | - E. M. Turner
- Red Cell Reference Laboratory; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
| | - R. L. Flower
- Clinical Services and Research; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
| | - C. A. Hyland
- Clinical Services and Research; Australian Red Cross Blood Service; Kelvin Grove QLD Australia
| |
Collapse
|